tiprankstipranks
Trending News
More News >
Advertisement
Advertisement

CVS Group Reports Revenue Growth and Expands Australian Operations Amid UK Market Challenges

Story Highlights
  • CVS Group reported a 5.4% revenue growth and aligned adjusted EBITDA for FY25.
  • The company expands in Australia while UK acquisitions are paused due to a CMA investigation.
  • Looking for the best stocks to buy? Follow the recommendations of top-performing analysts.
CVS Group Reports Revenue Growth and Expands Australian Operations Amid UK Market Challenges

Elevate Your Investing Strategy:

  • Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.

CVS Group plc ( (GB:CVSG) ) has shared an update.

CVS Group plc announced a trading update for the financial year ending June 30, 2025, highlighting a 5.4% revenue growth to £673.2 million and an expected adjusted EBITDA of approximately £134 million, aligning with market consensus. The company continues to expand in Australia with several acquisitions, while its UK acquisition activities are on hold pending a CMA investigation. The divestment of its Crematoria operations has reduced net bank borrowings and provided capital for further investments. Despite softer market conditions in the UK, CVS remains optimistic about its long-term growth prospects, supported by a strong balance sheet and a growing pet population.

The most recent analyst rating on (GB:CVSG) stock is a Buy with a £1500.00 price target. To see the full list of analyst forecasts on CVS Group plc stock, see the GB:CVSG Stock Forecast page.

Spark’s Take on GB:CVSG Stock

According to Spark, TipRanks’ AI Analyst, GB:CVSG is a Neutral.

CVS Group plc’s overall stock score reflects strong corporate actions and strategic decisions that bolster its market position. However, these positives are tempered by valuation concerns and a challenging technical outlook. Financial performance is solid but marred by profitability issues and increased leverage, necessitating careful management.

To see Spark’s full report on GB:CVSG stock, click here.

More about CVS Group plc

CVS Group plc is an AIM-listed provider of veterinary services with operations in the UK and Australia. The company focuses on delivering high-quality clinical services through its network of approximately 470 veterinary practices, including specialist referral hospitals and out-of-hours sites. CVS also operates laboratories offering diagnostic services and an online retail business called Animed Direct. The group employs around 8,900 personnel, including about 2,400 veterinary surgeons.

Average Trading Volume: 268,349

Technical Sentiment Signal: Hold

Current Market Cap: £859.4M

For detailed information about CVSG stock, go to TipRanks’ Stock Analysis page.

Disclaimer & DisclosureReport an Issue

Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App
1